Daejeon, South Korea

Gwan-Su Yi

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Korea Advanced Institute of Science and Technology. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gwan-Su Yi. Retrieved from https://idiyas.com/inventor/gwan-su-yi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gwan-Su Yi: Innovator in Pharmaceutical Composition

Introduction

Gwan-Su Yi is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the area of muscle-related diseases. His innovative work has the potential to improve the quality of life for many individuals suffering from these conditions.

Latest Patents

Gwan-Su Yi holds a patent for a pharmaceutical composition aimed at improving, preventing, or treating muscle-related diseases. This composition comprises ginsenoside Rh2 as an active ingredient. The invention provides a promising approach to preventing, alleviating, or treating muscular diseases, showcasing Yi's commitment to advancing medical science.

Career Highlights

Gwan-Su Yi is affiliated with the Korea Advanced Institute of Science and Technology, where he conducts research and development in pharmaceuticals. His work is characterized by a focus on innovative solutions that address pressing health issues.

Collaborations

Some of his notable coworkers include Yi Li and Yoon Hyeok Lee, who contribute to the collaborative environment that fosters innovation at their institution.

Conclusion

Gwan-Su Yi's contributions to pharmaceutical science, particularly through his patent on ginsenoside Rh2, highlight his role as an important inventor in the field. His work continues to inspire advancements in the treatment of muscle-related diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…